91大神

Clinical Trial</h3>\r\n<p><strong>Offered by:</strong> 91大神Children's<br>\r\n<strong>Locations: </strong>Delaware Valley; Jacksonville, Orlando in Florida</p>\r\n<h3>Trial Name</h3>\r\n<p>Key Adverse Events Following Childhood Cancer,/p&gt;</p>\r\n<h3>What is the trial about?</h3>\r\n<p>The goal of this study is to identify patients who are more likely to develop a late-occurring complication(s).</p>\r\n<h3>Who can participate?</h3>\r\n<p>Children with late-occurring complication(s) may be asked to be in this study.<br>\r\n</p>\r\n<h3>What is involved?</h3>\r\n<ul>\r\n<li>Participation in this study is expected to last 20-30 minutes.</li>\r\n<li>Most participants will be asked to provide about 2 teaspoons of blood. If your child is not able to give blood for some reason, then cells from his/her cheek can be collected.</li>\r\n</ul>\r\n"}} id=text-0f18781eb2 class=cmp-text>

Clinical Trial

Offered by: 91大神Children's
Locations: Delaware Valley; Jacksonville, Orlando in Florida

Trial Name

Key Adverse Events Following Childhood Cancer,/p>

What is the trial about?

The goal of this study is to identify patients who are more likely to develop a late-occurring complication(s).

Who can participate?

Children with late-occurring complication(s) may be asked to be in this study.

What is involved?

• Participation in this study is expected to last 20-30 minutes.
• Most participants will be asked to provide about 2 teaspoons of blood. If your child is not able to give blood for some reason, then cells from his/her cheek can be collected.

<strong>Trial Name: </strong>Key Adverse Events Following Childhood Cancer</p>\r\n<p><strong>ALTE#:</strong> 03N1</p>\r\n"}} id=text-47b5876f74 class=cmp-text>

Trial Name: Key Adverse Events Following Childhood Cancer

ALTE#: 03N1